Last reviewed · How we verify

NCT03915821

Memory Changes in Patients With Major Depression Disorder Treated With ECT

Completed NA Last updated 5 July 2023
What this trial tests

NA trial testing ECT in Depressive Disorder in 60 participants. Completed in 30 March 2022.

Timeline
15 December 2020
Primary endpoint
15 June 2021
30 March 2022

Quick facts

Lead sponsorAssiut University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposescreening
Enrollment60
Start date15 December 2020
Primary completion15 June 2021
Estimated completion30 March 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 18 to 50, any sex, with Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The basic memory changes (impairment) present in patients with major depression and the influence of the treatment with ECT.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of ECT

Trials testing the same drug.

Other recruiting trials for Depressive Disorder

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03915821.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing